High blood pressure, also known as hypertension, is one of the most common health conditions in the world.
It affects millions of people and is a major risk factor for heart attacks, strokes, heart failure, kidney disease, and other serious health problems.
Because high blood pressure often develops without obvious symptoms, many people do not realize they have it until damage has already occurred.
In the United States alone, high blood pressure affects more than 116 million adults. According to public health data, it contributed to more than 670,000 deaths in 2020.
Despite the availability of many effective medications, controlling blood pressure remains a challenge for a large number of patients. Some people do not respond well to treatment, while others experience side effects that make it difficult to continue taking their medication.
Now, researchers at the University of Virginia have made an important discovery that could eventually lead to a new generation of blood pressure treatments.
Their findings provide fresh insight into how blood vessels control blood pressure and may help scientists develop more targeted therapies in the future.
To understand the discovery, it helps to know how blood vessels work. The walls of blood vessels contain smooth muscle cells. These cells act like tiny adjustable bands that can tighten or relax.
When the muscle cells tighten, blood vessels become narrower, making it harder for blood to flow through them. This increases blood pressure. When the muscle cells relax, blood vessels widen, allowing blood to flow more easily and lowering blood pressure.
A key factor controlling this process is calcium. Calcium is widely known for its role in building strong bones, but it is also essential for many functions throughout the body. It helps muscles contract, supports nerve communication, and plays a role in many cellular processes.
Inside blood vessel muscle cells, calcium acts as a signaling molecule. Changes in calcium levels help determine whether the muscle cells tighten or relax. Because calcium plays such an important role in blood pressure regulation, many commonly prescribed blood pressure medications work by limiting the movement of calcium into these cells.
These medicines, known as calcium channel blockers, help blood vessels remain relaxed and open. They are widely used and can be very effective. However, calcium is important in many other tissues and organs as well. As a result, these medications can sometimes cause side effects such as dizziness, swelling, headaches, constipation, or fatigue.
The new study focused on what happens inside smooth muscle cells at a much smaller scale. Researchers discovered tiny structures called nanodomains. These microscopic areas act as specialized signaling centers within the cells. Although extremely small, they play a major role in controlling whether blood vessels tighten or relax.
The scientists found that there are two main types of nanodomains working together. One type sends signals that encourage blood vessels to tighten, while the other type promotes relaxation. In healthy blood vessels, these two systems remain in balance. This balance allows the body to adjust blood flow and blood pressure according to its needs.
However, the researchers found that this balance is disrupted in people with high blood pressure. The nanodomains responsible for tightening blood vessels become overactive, while the nanodomains that promote relaxation become weaker.
This imbalance causes blood vessels to remain more constricted than they should be, leading to persistently elevated blood pressure.
This discovery is important because it identifies a potential new target for future treatments. Instead of affecting calcium activity throughout the entire body, future medications might be designed to specifically target these nanodomains inside blood vessel cells.
Such an approach could provide a more precise way to lower blood pressure. By correcting the imbalance between the two types of nanodomains, scientists may be able to restore healthy blood vessel function without interfering with calcium’s many other roles in the body. This could potentially reduce the side effects associated with current medications.
The research is still at an early stage, and more studies will be needed before new treatments become available. Scientists must first learn more about how these nanodomains work and determine the safest and most effective ways to target them.
Clinical trials would also be required before any new therapy could be approved for patients.
Even so, experts view the findings as an exciting advance. High blood pressure has been studied for decades, yet many aspects of how blood vessels regulate pressure remain poorly understood. Discoveries like this help reveal the complex biological processes that drive hypertension and offer new directions for treatment development.
For patients living with high blood pressure, the study provides hope that future therapies may be more effective and better tolerated than some current options. Rather than simply controlling symptoms, these treatments could address underlying cellular mechanisms that contribute to the disease.
As researchers continue to explore the role of nanodomains in blood vessel health, the findings may eventually lead to safer and more personalized approaches to managing hypertension.
Given the enormous impact of high blood pressure on public health, even small improvements in treatment could benefit millions of people worldwide and help reduce the burden of heart disease and stroke.
If you care about high blood pressure, please read studies about unhealthy habits that may increase high blood pressure risk, and drinking green tea could help lower blood pressure.
For more information about high blood pressure, please see recent studies about what to eat or to avoid for high blood pressure, and 12 foods that lower blood pressure.
